https://www.live-feeds.com/feed/abbott-to-pay-670-million-to-settle-baby-formula-litigationContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/abbott-to-pay-670-million-to-settle-baby-formula-litigationhttps://www.live-feeds.com/feed/abbott-to-pay-670-million-to-settle-baby-formula-litigation#u46707Sun, 23 Aug 2026 07:20:14 +0000Abbott will pay $670 million to resolve 2,000 claims regarding its specialty infant formulas. The agreement settles lawsuits alleging that the company's products caused necrotizing enterocolitis (NEC) in preterm infants. This settlement includes the resolution of an appeal tied to a previous $495 million verdict. While this payment addresses a significant portion of the ongoing litigation, the company is settling specific claims rather than all possible disputes related to its preterm formula products.Why it mattersNEC is a severe intestinal disease that primarily affects premature babies